Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02586987
Title A Study to Assess the Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of Ascending Doses of Selumetinib in Combination With MEDI4736 in Patients With Advanced Solid Tumours
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.